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Abstract: A simple, rapid and accurate procedure for the quantitative determination
of quercetin in its pure form and in formulations has been developed. The method is
based on the spectrophotometric determination of a complex formed between
quercetin and potassium titanyloxalate in 50 % ethanolic solutions. To characterize
the quercetin titanyloxalato complex, the stability constants of the complex were
determinated potentiometrically and spectrophotometrically at different tempera-
tures (T = 26.0 oC, 34 oC and 39.0 oC), as well as at different ionic strengths (I = 5.0 
10-4 mol dm-3, 3.0  10-2 mol dm-3 and 6.0  10-2 mol dm-3) and the thermodynamic
parameters were calculated. As quercetin is usually conjugated to vitamin C in phar-
maceutical formulations, two procedures for the quantitative determination of
quercetin by this complexing reaction were tested  both in the absence and pres-
ence of ascorbic acid. In both procedures, the Beer law was obeyed over the same
concentration range of quercetin, i.e., 0.85 g mL-1  16.9 g mL-1. In the first pro-
cedure in the absence of ascobic acid the molar absorptivity coefficient of the
quercetin-titanyloxalate complex is a = 2.49  104 mol-1 dm3 cm-1, Sandells sensi-
tivity of the method is S = 1.35  10-2 g cm2 and the detection limit is d = 0.67 g
mL-1. Whereas, in the presence of ascorbic acid (second procedure) a = 3.04  104
mol-1 dm3 cm-1, S = 1.11  10-2 g mL-1. The proposed method was verified for the
determination of quercetin in pharmaceutical dosage forms.
Keywords: quercetin, potassium titanyloxalate, spectrophotometric determination,
stability constants, dosage form.
INTRODUCTION
Quercetin (C15H10O7, 2-(3,4-dixydroxyphenyl)-3,5,7-trixydroxy-4H-1-ben-
zopyran-4-one), a plant pigment primary found in onions, tea, apples and berries,
is a very important natural compound. It is a building block for several other mem-
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bers of the flavonoid family, the largest and mostly distributed group of secondary
plant metabolites. Quercetin, both pure and in its glycosidic forms, exhibits a broad
spectrum of biological activites.1 For example, due to its metal chelation and free radi-
cal scavenging capacities, quercetin shows potent antioxidant properties and protects
against many different disorders: asthma, heart disease, cancer, etc.24
Up to now, HPLC59 and CE1012 using various detection methods have been the
most common and widely spread techniques which have been utilized to purify and
measure low levels of quercetin. The majority of these techniques is devoted to the
separation, identification and quantification of quercetin from plant extracts, food and
plant based beverages, as well as from body fluids. These techniques require expen-
sive instrumentation, as well as lengthy and complicated preparation procedures
which are not necessary for routine analysis in pharmaceutical dosage forms. There-
fore, the aim of this study was to develop a simple, inexpensive and time saving proce-
dure for the quantitative determination of quercetin in formulations.
Due to its structure (carbonyl group in C4, hydroxyl group in C3 position in
ring A and ortho OH groups in ring B), quercetin easily forms colored complexes





16 This feature of quercetin can be utilized for its
spectrophotometric determination. In a previous work,16 it was found that the
complexing reaction with potassium titanyloxalate is particularly suitable for ana-
lytical purpose because solutions of quercetin titanyloxalate complex (Q–TiOx)
extibit excellent characteristics for detection by spectrophotometric techniques
(intense color, clear, translucent and stable in time).
For this reason, in this work the conditions of the reaction between quercetin
and K2TiO(C2O4)2 were optimized to proivde a simple and sensitive procedure
for the determination of quercetin in pharmaceutical dosage forms. In this way, ex-
pensive instrumental techniques and complicated procedures, generally used for
quercetin determination, can be avoided. The stability constants and thermody-




Potassium titanyloxalate and potassium hydrogen phthalate (Anala R) were obtained from
BDH (Poole, England), quercetin, absolute ethanol, ascorbic acid, sodium nitrate and carbonate free
sodium hydroxide were from Merck (Darmstadt, Germany). Quercetin + C capsules were obtained
from Twin Laboratories Inc. (Ronkonkoma, New York, USA). All reagents were of p.a. grade and
were used without further purification.
The sodium hydroxide was standardized by potentiometric titration against potassium hydro-
gen phthalate (dried 1 h at 120 oC). The stock solution of potassium titanyloxalate was prepared in
deionized water that had been boiling 30 min under a nitrogen atmosphere. Stock solutions of
quercetin and sample solutions of pharmaceutical dosage forms were stored in a refrigerator and
protected from sunlight.
754 KUNTI] et al.
Instrumentation
An ordinary saturated combined electrode (CW. 733, Russel, Auchtermuchy, Fife, U.K.) and a
pH-meter (Radiometer, Copenhagen, Denmark) were used for pH measurements. Buffers for ethanol–wa-
ter mixture (0.01 mol dm-3 oxalic acid and 0.01 mol dm-3 lithium hydrogen oxalate, as well as 0.01mol
dm-3 succinate and 0.01 mol dm-3 lithium succinate)17, pH 2.5 and pH 5.1 were used for the calibration of
the pH-meter. The concentration of hydrogen ions were calculated from the activity of hydrogen ions and
from the activity coefficient which was corrected according to the temperature, the ionic strength as well as
the dielectric constant for a 50 % ethanol-water mixture. The temperature was controlled within:  0.2 °C
with a circulating water thermostat (Serie U, MLW, Freital, Germany). Spectrophotometric measurements
were performed on a Beckman DU-650 spectrophotometer (Fullerton, USA) using a 1 cm quartz cell.
2.3. Potentiometric measurements
The potentiometric titrations were carried out in a 51 mL glass vessel, surrounded by a
thermostating jacket, and tightly closed by a cover with five openings. A thermometer, the combined
electrode, nitrogen inlet tubes and a titration burette were introduced through four of the openings,
whereas the remaining opening was closed with a glass stopper. To commence the experiment, 20.0
mL of the quercetin solution in absolute ethanol Q = 5.0  10-3 mol dm-3, 5.0 mL of an aqueous so-
lution of potassium titanyloxalate K2TiO(C2O4)2 = 5.0  10
-3 mol dm-3 and the required volume
(either 0.1 mL, 0.6 mL or 1.2 mL) of an aqueous solution of sodium nitrate NaNO3 = 2.0 mol dm
-3
were transferred into the reaction vessel and diluted with deionized water to a final volume V = 40.0
mL. In this way, the concentrations of quercetin and potassium titanyloxalate in the 50% ethanolic
solution were Q = 2.5  10-3 mol dm-3 and K2TiO(C2O4)2 = 6.3  10
-4 mol dm-3, 3.0  10-2 mol
dm-3. The reaction mixture was thermostated at the required temperature (T = 26.0 oC, 34.0 oC or
39.0 oC), stirred at 900 rpm, and deoxygenated by bubbling a stream of nitrogen through the liquid
phase for 20 min. The inert atmosphere was maintained during titration by continuously passing ni-
trogen above the solution. The titration was performed with a carbonate free 50 % ethanolic solu-
tions of sodium hydroxide, NaOH = 4.8  10-2 mol dm-3. All potentiometric titrations, with about
180 experimental points each, were done in triplicate.
Spectrophotometric measurements
Spectrophotometric determination of the stability constants. To determine the stability constants
of the Q–TiOx complex at different pH values, the following solutions were prepared: quercetin in 50
% ethanol Q = 5.0  10-4 mol dm-3 and a solution containing both quercetin Q = 5.0  10-4 mol
dm-3 and potassium titanylaxalate K2TiO(C2O4)2 = 2.5  10
-5 mol dm-3 in 50 % ethanol. The
UV-VIS absorption spectra were recorded at different pH values. In the case of pure quercetin, 50 %
ethanol was used as the blank. For the second solution, a 50 % ethanolic solution of pure quercetin, at
the same pH, temperature and ionic strength as in the mixture, was used as the blank.
Procedures for the spectrophotomertric determination of quercetin via Q–TiOx complex. As
quercetin is often conjugated to vitamin C in pharmaceutical complex formulations, two procedures
for were designed the determination of quercetin via the Q–TiOx complex, one in the absence (A)
and the other in the presence of ascorbic acid (B).
Procedure A
Stock solutions of quercetin in absolute ethanol, Q = 1.69  102 g mL-1 and potassium
titanyloxalate in water K2TiO(C2O4)2 = 2.83  10
3
g mL-1, were prepared. To construct the cali-
bration curve for quercetin a series of standard stock solutions of the complex, in which amount of
quercetin was varied from 0.67 g mL-1 to 18.6 g mL-1, whereas the concentration of potassium
titanyloxalate was kept constant at K2TiO(C2O4)2 = 3.54  10
2
g mL-1, were prepared by mixing
appropriate volumes of the standard stock solution of quercetin (V1), absolute ethanol (V2), water
(V3) and the standard stock solution of potassium-titanyloxalate (V4). The standard solutions were
prepared in 20 mL volumetric flasks, the reaction were mixed in the order given above, and the fol-
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lowing relations were obeyed V1 + V2 = 10 mL and V3 + V4 = 10 mL. The volumetric flasks were
filled to the mark with 50 % ethanol. The values of the pH and ionic strength were adjusted accord-
ing to the procedure previously described in details.18
Procedure B
In addition to the stock solutions of quercetin and potassium titanyloxalate, in the same con-
centrations as given in Procedure A, a stock solution of ascorbic adid, C6O6H7 = 1.88 x 10
2
g
mL-1 was prepared. To construct the calibration curve for quercetin the determination of a series of
standard stock solutions was prepared in the same manner as described in procedure A, except that a
constant volume of the ascorbic acid solution was added (V3), to all of them, giving a final concen-
tration of ascorbic acid, C6O6H7 = 17.17 g mL
-1. These standard solutions were allowed to stabi-
lize for at least 20 min and the measurements were performed only after this time had elapsed.
Sample preparation from pharmaceutical formulations. For quercetin determination in Quer-
cetin + C capsules, twenty capsules were weighed and the average value per capsule was calculated.
An amount equivalent to the average weight of two capsules (containing 500 mg of quercetin and 1400
mg of Vitamin C, according to the manufacturer’s declaration) was weighed, dissolved in absolute
ethanol to a volume of 1000 mL, shaken for 15 min in an ultrasonic bath and filtered through a
Whatman No 1 filter paper. The filtered solution was collected in a clean 1000 mL volumetric flask and
filled to the mark with absolute ethanol to compensate for the evaporated solvent. Then, 16.9 mL were
pipetted into a 100 mL flask, and diluted with absolute ethanol to the mark. From this solution, 2.0 mL
aliquots were transferred and further treated in accordance with procedures A and B. The whole proce-
dure of sample preparation was repeated five times, and the amount of quercetin in the sample was de-
termined as the average of five measurements.
RESULTS AND DISCUSSION
Potentiometric determination of the stability constants of the Q–TiOx complex
Characteristic titration curves obtained for the titration of the Q–TiOx com-
plex with NaOH solutions of different ionic strengths are presented in Fig. 1.
The average number of ligands (n) that binds to one metal ion was calculated
for each point of all the titration curves from the equation:
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Fig. 1. Titrations curves of the Q–TiOx complex obtained
at T = 26.0 oC for different ionic strengths: I = 5.0  10-4








where c is the initial concentration of the protonated ligand (i.e., quercetin), cor-
rected at each point on the titration curve for the volume change caused by the ad-
dition of the standard alkali, Q is the free quercetin concentration and cM is the
initial metal ion concentration (i.e., potasiumtitanyloxalate).  is calculated from:
 = 1 + cH K1Q + 2c
2
H2Q, where cH is the concentration of hydronium ions and
K1Q and 2Q are the dissociation constants of quercetin alone.19
The resulting complex formation curve is shown in Fig. 2 from which the maximal
value for the average number of ligands is determined to be n = 2. This implies that two
stability constants, partial and cumulative, exist for the same temperature and ionic
strength. In a previous work,16 the maxiumum number of ligand (N) for the Q–TiOx
complex was found to be two (N = 2). Therefore, the following relation between the av-


















where K1 and 2 are the partial stability constant and the cumulative constant of the
complex, respectively, according to Irving and Rossotti.21 Thus, the overall reaction
between quercetin and the titanyloxalate anion is:
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Fig. 2. The complex formation curve, n = f(pH) obtained at T = 26.0 oC, I = 5.0  10-3 mol dm-3,
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The stepwise formation constants, K1 and K2, corresponding to the stepwise equi-
librium reactions (4) and (5), respectively, can be calculated from equations (6) and (7).
K1 =
[TiO(C O )(C H O )]
[C H O ][TiO(C O ) ]
2 4 15 9 7
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an the cumulative stability constant 2, for the overall reaction,is:
2 = K1K2 =
[TiO(C O )(C H O ) ]
[C H O ] [TiO(C O ) ]




























are obtained from the straight line dependence the values of 2, from the slope, and
– K1, from the intercept (Fig. 3). The values of the thermodynamic stability con-
stants (2
0), are obtained by extrapolating log 2 = f(I
1/2) to infinite dilution. The
values of the partial (K1), cumulative (2) and thermodynamic stability constants
(2
0) for the Q–TiOx complex determined in this way are given in Table I.
Therefore, the values of the thermodynamic parameters G, H and S for the
complex formation were determined. Changes in the standard free energy were es-
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Fig. 3. Graphic presentation of
function (9) obtained at T = 26.0
oC, I = 5.0  10-4 mol dm-3, Q =
2.5  10-3 mol dm-3 and
K2TiO(C2O4)2 = 6.3  10
-4
mol dm-3.
timated from the average value of the thermodynamic stability constants, G =
–RT ln 2
0, whereas the values of H and S were estimated from the linear de-
pendence of the logarithm of the thermodynamic stability constant (2
0) on the in-
verse temperature, log 2
0 = f(1/T), implicitly assuming that they were not temper-
ature dependent in the investigated range. In this way, the values G299 = – 68 kJ
mol1, G307 = – 71 kJ mol
1, G132 = – 71 kJ mol
1, H = 41 kJ mol1, and S =
0.4 kJ mol1 K–1 were obtained, showing that the reaction between quercetin and
potassiumtitanyloxalate is thermodynamically favorable, and occurs spontane-
ously in the investigated temperature interval.
Spectrophotometric determination of the stability constants of the Q–TiOx complex
In a 50 % ethanol-water solution, quercetin and potassiumtitanyloxalate form
a 2:1 complex having a distinctive yellow-orange color.16 To calculate the concen-
tration stability constants for the Q–TiOx complex at different ionic strengths the
Bjerrum’s method22 modified in a manner described earlier in detail,15,18 was
apphed. The cumulative stability constants of the Q–TiOx complex are given in
Table I. As can be seen the agreement with the stability constants obtained
potentiometrically is good.






stability constant, log 2
Cumulative concentration
stability constant, log 2
26.0 0 5.5 12.0* 11.8
5.0  10-4 5.5 12.0 11.8
3.0  10-2 5.3 11.9 10.9
6.0  10-2 5.2 11.8 10.8
34.0 0 5.6 12.1 11.9
5.0  10-4 5.6 12.1 11.9
3.0  10-2 5.5 11.7 11.3
6.0  10-2 5.5 11.6 11.2
39.0 0 5.6 12.2 12.1
5.0  10-4 5.5 12.2 12.0
3.0  10-2 5.4 11.6 11.4
6.0  10-2 5.2 11.5 11.0




After evaluating the thermodynamic data and verifying that a sufficiently stable
complex between quercetin and potassium titanyloxalate is formed at all the investi-
gated temperature as well as ionic strengths it was reaffirmed that the previously deter-
mined conditions, 50 % ethanol as solvent,  = 430 nm, pH 7.2 ionic strength I = 7.5 
105 mol dm3 and temperature T = 23.0 oC, are the most suitable for the spectropho-
tometric determination of quercetin via the complexing reaction between quercetin
and potassium titanyloxalate. Under those conditions, both procedures, A and B gave
a linear relationship between the absorbance and the concentrations of quercetin over
the same concentration range 0.85 g mL1 – 16.9 g mL1, and with the highest sen-
sitivity. Compared to procedure A, procedure B requires a longer time, because the
standard solutions have to stabilize for at least 20 minutes. Namely, in the presence of
ascorbic acid, the absorbance of the Q–TiOx complex changes rapidly during the first
20 minutes, and remains constant thereafter (Fig. 4). This is due to the well-known ca-
pability of quercetin to reduce the ascorbyl radical – the so-called ascorbate protective
function.23 The parameters of the linear calibration curves (A = X c + Y, where A is the
absorbance of a 1 cm layer, X is the slope, Y is the intercept, and c is the concentration
of quercetin in g mL1), as well as the corresponding correlation coefficients (r)
aregiven in Table II, together with the molar absorption coefficients (a), Sandell’s sen-
sitivity (S) and the limits of detection (d).
Both procedures, A and B, were tested for precision, sensitivity and repro-
ducibility. The precision was established by repeated assays (n = 5) using three dif-
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Fig. 4. Absorbance at  = 430 nm of the Q–TiOx complex in the presence of ascorbic acid. Q =
8.45 g mL-1, K2TiO(C2O4)2 = 354 g mL
-1, C6O6H7 = 17.17 g mL
-1, T = 26.0 oC,
I = 7.5  10-5 mol dm-3 and pH 7.2.
ferent concentration of quercetin that are within the Beer’s law limits, Table III.
The standard deviations 0.05 – 0.09 and RSD values less than 3 %, indicate high
precision and reproducibility.
Applicability of both procedures was tested for Quercetin + C capsules, Table
III. Both the proposed procedures for the spectrophotometric determination of
quercetin are applicable. Although the recovery values lie within the required
range of ± 5 % (Ph EUR 97), procedure A is of lower accuracy and is not recom-
mendable in the case of high dosage drugs. Procedure B gives excellent accuracy
and is recommendable for quercetin determination in the presence of vitamin C.
TABLE II. Analytical parameters for the determination of quercetin concentrations at T = 23.0 oC
and  = 430 nm
Procedure A B
Regression equation*
Slope, x 0.0738 0.0809
Intercept, y 0.0074 0.0071
Correlation coefficient,r 0.999 0.998
Molar absorptivity/10-4 dm3 mol-1 cm-1 2.50 3.04
Sandell’s sensitivity/g cm-2 0.0135 0.0111
Limit of detection**/g mL-1 0.67 0.72
*A = x C + y, where C is the concentration in g mL-1; **Defined as the concentration that produces a
signal-to-noise ratio of 3
TABLE III. Precision and recovery of quercetin concentration in bulk drugs capsules
Sample Procedure
Qg mL-1 Found ± Sd/g mL-1 RSD RC/(%)
Quercetin bulk drug A 1.05 1.09 ± 0.06 2.02 103.80
7.72 7.74 ± 0.06 0.60 100.25
15.20 15.33 ± 0.09 1.30 100.85
B 1.05 1.02 ± 0.05 1.80 97.14
7.72 7.70 ± 0.05 0.50 99.74
15.20 15.17 ± 0.08 1.20 99.80
Quercetin + C capsules A 8.45 8.83 ± 0.45 2.80 104.49
B 8.45 8.42 ± 0.09 0.40 99.64
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I Z V O D
ODRE\IVAWE KVERCETINA U FARMACEUTSKIM PREPARATIMA
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Predlo`en je brz, jednostavan i ta~an metod za odre|ivawe kvercetina u farma-
ceutskim sirovinama i doziranim oblicima. Metod je baziran na spektrofotometrij-
skom odre|ivawu kompleksa formiranog izme|u kvercetina i kalijum-titaniloksa-
lata u 50 % etanolu. Odre|ene su konstante stabilnosti kvercetin titaniloksalat-
nog kompleksa potenciometrijski i spektrofotometrijski na razli~itim tempera-
turama (T = 26,0 oC, 34,0 oC, 39,0 oC) i jonskim ja~inama (I = 5,0  10-4 mol dm-3, 3,0  10-2
mol dm-3, 6.0  10-2 mol dm-3) i izra~unati su termodinami~ki parametri. Kako se
kvercetin uobi~ajeno nalazi zajedno sa vitaminom C u doziranim oblicima, predlo-
`ene su dve procedure za odre|ivawe kvercetina: bez i u prisustvu askorbinske
kiseline. U obe predlo`ene procedure, Beer-ov zakon va`i u oblasti 0,85 g mL-1 – 16,9
g mL-1 kvercetina. Prema prvoj proceduri, molarni apsorpcioni koeficijent kver-
cetin–titaniloksalatnog kompleksa je a = 2,49  104 mol-1 dm3 cm-1, Sandelova oset-
qivost metode je S = 1,35  10-2 g cm-2, a limit detekcije je d = 0,67 g mL-1. Prema dru-
goj proceduri, a = 3,04  104 mol-1 dm3 cm-1, S = 1,11  10-2 g cm-2 i d = 0,72 g mL-1.
Predlo`eni metod je primewen za odre|ivawe kvercetina u doziranim oblicima.
(Primqeno 10. maja, revidirano 9. jula 2004.)
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